New Mountain Capital/Topix Pharmaceuticals
Andre Moura is a Managing Director at New Mountain Capital, which he joined in 2005. New Mountain Capital manages private equity, public equity and credit capital with aggregate assets under management totaling more than $20.0 billion.
Mr. Moura has also been the Chairman of Topix Pharmaceuticals since 2016, when New Mountain Capital acquired a controlling stake in Topix. With over 30 years of skin care experience, Topix is a leader in physician dispensed skin care.
Before New Mountain, he worked at McKinsey, where he helped to advise companies in the healthcare and consumer sectors.
In addition to Topix, Mr. Moura currently serves as a director of Avantor, Bellerophon, Gelest, Alteon Health, Medical Specialties Distributors and Sparta Systems. He previously served as a director of NuSil and ACA Compliance Group. He received his AB in Computer Science from Harvard College and his MBA from Harvard Business School, where he was a Baker Scholar.